Oculis announces patient dosing in its diamond study DIAMOND, its first phase 3 study with OCS-01. bit.ly/3kzvZqW
English
VI Partners
2 posts
VI Partners
@VI_Partners_AG
VC firm based out of Switzerland. Investing in outstanding teams in Healthcare and Technology
Switzerland Katılım Ekim 2020
42 Takip Edilen22 Takipçiler
VI Partners Portfolio Araris company expands Scientific Advisory Board with appointment of Dr. Jeff Sharman and Dr. Clive Stanway. #AntibodyDrugConjugates bit.ly/3kuO61j
English